AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 45 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $9,000 | -18.2% | 16,272 | +30.3% | 0.00% | – |
| Q3 2016 | $11,000 | -52.2% | 12,492 | -48.3% | 0.00% | – |
| Q2 2016 | $23,000 | -81.0% | 24,154 | -81.6% | 0.00% | – |
| Q1 2016 | $121,000 | -32.0% | 131,494 | -6.7% | 0.00% | – |
| Q4 2015 | $178,000 | +9.2% | 140,888 | +4.5% | 0.00% | – |
| Q3 2015 | $163,000 | -32.4% | 134,846 | -2.6% | 0.00% | – |
| Q2 2015 | $241,000 | +12.1% | 138,410 | -6.5% | 0.00% | – |
| Q1 2015 | $215,000 | +61.7% | 148,065 | -6.3% | 0.00% | – |
| Q4 2014 | $133,000 | -18.4% | 158,097 | +7.7% | 0.00% | – |
| Q3 2014 | $163,000 | -43.4% | 146,811 | -6.8% | 0.00% | – |
| Q2 2014 | $288,000 | -86.6% | 157,470 | -89.0% | 0.00% | -100.0% |
| Q1 2014 | $2,149,000 | -17.6% | 1,437,770 | +0.9% | 0.00% | 0.0% |
| Q4 2013 | $2,608,000 | -38.4% | 1,424,882 | -30.6% | 0.00% | 0.0% |
| Q3 2013 | $4,231,000 | +0.3% | 2,053,915 | +21.7% | 0.00% | -50.0% |
| Q2 2013 | $4,219,000 | – | 1,687,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VI & Co. LLC | 675,242 | $1,958,000 | 100.00% |
| NEA Management Company, LLC | 16,362,694 | $47,452,000 | 2.11% |
| Prosight Management, LP | 1,043,550 | $3,026,000 | 1.90% |
| New Leaf Venture Partners, L.L.C. | 964,520 | $2,797,000 | 1.51% |
| RA Capital Management | 5,062,759 | $14,682,000 | 1.12% |
| X-Square Capital, LLC | 231,434 | $671,000 | 0.71% |
| 683 Capital Management, LLC | 2,500,000 | $7,250,000 | 0.64% |
| Avoro Capital Advisors LLC | 3,231,893 | $9,372,000 | 0.45% |
| EAM Global Investors LLC | 244,768 | $710,000 | 0.37% |
| Polar Capital LLP | 7,877,429 | $22,845,000 | 0.23% |